OZ Management LP Purchases New Position in Shire PLC (SHPG)
OZ Management LP purchased a new position in shares of Shire PLC (NASDAQ:SHPG) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 395,652 shares of the biopharmaceutical company’s stock, valued at approximately $71,720,000. OZ Management LP owned 0.13% of Shire as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in SHPG. Abrams Capital Management L.P. bought a new position in Shire during the third quarter worth about $407,338,000. Third Point LLC bought a new position in Shire during the third quarter worth about $290,032,000. PointState Capital LP lifted its stake in Shire by 4,642.0% during the second quarter. PointState Capital LP now owns 711,296 shares of the biopharmaceutical company’s stock worth $120,067,000 after purchasing an additional 696,296 shares during the period. Kepos Capital LP lifted its stake in Shire by 400.0% during the third quarter. Kepos Capital LP now owns 425,000 shares of the biopharmaceutical company’s stock worth $77,040,000 after purchasing an additional 340,000 shares during the period. Finally, LMR Partners LLP bought a new position in Shire during the second quarter worth about $55,664,000. Hedge funds and other institutional investors own 20.49% of the company’s stock.
NASDAQ:SHPG opened at $171.50 on Wednesday. Shire PLC has a 1 year low of $123.73 and a 1 year high of $182.47. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.92 and a quick ratio of 0.51. The company has a market capitalization of $53.37 billion, a PE ratio of 11.32, a PEG ratio of 1.59 and a beta of 1.01.
A number of research analysts have commented on the stock. BidaskClub cut shares of Shire from a “buy” rating to a “hold” rating in a research note on Friday, November 30th. B. Riley reiterated a “buy” rating on shares of Shire in a research note on Tuesday. Zacks Investment Research reiterated a “hold” rating on shares of Shire in a research note on Thursday, November 15th. ValuEngine upgraded shares of Shire from a “sell” rating to a “hold” rating in a research note on Friday, August 24th. Finally, Berenberg Bank cut shares of Shire from a “buy” rating to a “hold” rating in a research note on Friday, September 7th. Nine equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $201.11.
ILLEGAL ACTIVITY WARNING: “OZ Management LP Purchases New Position in Shire PLC (SHPG)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.watchlistnews.com/oz-management-lp-purchases-new-position-in-shire-plc-shpg/2662814.html.
Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.
Further Reading: Buyback
Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).
Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.